The Team

Aram T. Salzman, President & CEO
Mr. Salzman has more then 17 years of experience in Healthcare and Life Sciences Business Development, Marketing, and Sales. He founded NovoBiotic Pharmaceuticals with Kim Lewis, and Slava Epstein in April of 2003. Prior to NovoBiotic, he was employed at Cerner Corporation, the leading U.S. supplier of healthcare information technology. Mr. Salzman has also worked for Siemens Medical Systems and PerSeptive Biosystems.

Losee Ling, Ph.D., V.P. of Biology
Dr. Ling has extensive experience in pathogen genetics, microbiology, and screening for novel antimicrobial agents. She has led multi-disciplinary teams from assay development to lead optimization, screening both synthetic small molecules and natural products. Prior to NovoBiotic Dr. Ling was at Genome Therapeutics, Waltham, MA for over 10 years.

Dallas Hughes, Ph.D., V.P. of Research and Development
Dr. Hughes has over 22 years of experience in preclinical research and development, microbiology, and drug discovery. His experience in natural products has resulted in the discovery and preclinical development of several novel drug candidates. Prior to joining NovoBiotic Dr. Hughes was a Sr. V.P. at Cetek Pharmaceuticals.

Kim Lewis, Ph.D., Consultant
Dr. Lewis is a co-founder of the company and a specialist in multi-drug resistance and drug discovery. He is Professor and Distinguished Research Fellow at Northeastern University. Dr. Lewis is the co-inventor of the method for growing unculturable bacteria that forms the core of NovoBiotic's intellectual property.

Slava Epstein, Ph.D., Consultant
Dr. Epstein is a co-founder of the company; his specialty is environmental microbiology. He is an Assistant Professor of Biology at Northeastern University. Together with Dr. Lewis, Dr. Epstein co-invented the method to grow unculturable microorganisms. Dr. Epstein developed innovative methods for enumeration of marine microorganisms, their in situ study and their molecular diversity.

Top